Antiretroviral therapy coverage for PMTCT in Ireland
Ireland: Antiretroviral therapy coverage for PMTCT was 100.0% in 2024. ▲ Rising
Antiretroviral therapy coverage for PMTCT in Ireland, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2024, antiretroviral therapy coverage for pmtct in Ireland stood at 100.0%. That is the highest value across all 19 years on record.
Compared with earlier readings it is unchanged over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Ireland peaked at 100.0% in 2015 and was at its lowest, 90.0%, in 2000.
Ireland ranks 1st of 84 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 19 years of available data.
Antiretroviral therapy coverage for PMTCT in Ireland, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 90.0% | — |
| 2001 | 90.0% | +0.0% |
| 2002 | 90.0% | +0.0% |
| 2003 | 90.0% | +0.0% |
| 2004 | 90.0% | +0.0% |
| 2005 | 90.0% | +0.0% |
| 2006 | 90.0% | +0.0% |
| 2007 | 90.0% | +0.0% |
| 2008 | 90.0% | +0.0% |
| 2009 | 90.0% | +0.0% |
| 2015 | 100.0% | +11.1% |
| 2016 | 100.0% | +0.0% |
| 2017 | 100.0% | +0.0% |
| 2018 | 100.0% | +0.0% |
| 2019 | 100.0% | +0.0% |
| 2020 | 100.0% | +0.0% |
| 2022 | 100.0% | +0.0% |
| 2023 | 100.0% | +0.0% |
| 2024 | 100.0% | +0.0% |
Ireland compared with similar countries
- Ireland's 100.0% is above the median for high income countries, which is 89.0%, 1.1× the median. (8 countries reporting)
- Ireland's 100.0% is above the median for Europe & Central Asia, which is 91.0%, 1.1× the median. (8 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 90.0% | 90.0% | 90.0% | 10 |
| 2010s | 100.0% | 100.0% | 100.0% | 5 |
| 2020s | 100.0% | 100.0% | 100.0% | 4 |
Countries ranked near Ireland
More health data for Ireland
- Un projection of annual infant deaths, annual growth rate -4.76 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.89 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,122 deaths per 1,000 people (2090)
- Number of infants who die before age 1 20 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.7228 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.026 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.6489 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Ireland?
- Antiretroviral therapy coverage for pmtct in Ireland was 100.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Ireland?
- The highest recorded value was 100.0% in 2015.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Ireland?
- The lowest recorded value was 90.0% in 2000.
- How does Ireland rank for antiretroviral therapy coverage for pmtct?
- Ireland ranks 1st out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Ireland?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this Ireland data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).